Immediate Impact
50 hit
Citing Papers
Multidrug-resistant Gram-negative bacterial infections
2025 Hit
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Hit
Works of Wen‐Chien Ko being referenced
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales causing urinary tract infection in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2020
2023
Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020
2022